Building upon the anticipated role of FANCD2 in human malignancy, we have executed a comprehensive pan-cancer analysis aimed at characterizing the expression profile of FANCD2 across diverse cancer types, while delving further into its prognostic potential, genetic alterations, association with the cancer immune microenvironment, and regulatory network. Here, FANCD2 is linked to cancer.